Stryker has taken a 5.3% tumble in the last six months, yet it’s outpaced the S&P 500, showing it still packs a punch.

Stryker is a global player in the medical device industry, with over $20 billion in revenue and a presence in 75 countries.

Although Stryker has dropped 5.3% to $335.22 per share over the past six months, it has beaten the S&P 500 by 8.6 percentage ...

Analysts are giving Stryker’s stock a collective high five, assigning it a “Moderate Buy” based on 20 recent ratings. Sixteen ...

Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its first quarter 2025 results. The webcast can be accessed at Stryker - Events & Presentations. An archive of the ...

The Centers for Medicare and Medicaid Services estimates U.S. health care spending will grow 5.6% annually through 2032, ...

New US tariffs could disrupt the medtech industry, impacting major companies like Boston Scientific and Stryker. Read more ...

From acquisitions and new leadership, here are six key updates from spine and orthopedic device companies since March 26: 1.

In Forbes‘ World’s Billionaires list, released April 1, highlights the world’s wealthiest individuals. Below is a breakdown ...

When Susan Stryker gives lectures around the country, she often starts with the same sentence: “Thank you for inviting me ...

Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business ...

We recently published a list of the 10 Best Robotics Stocks to Buy According to Billionaires. In this article, we are going ...